The PQRI BTC 2021 Webinar: Exploring the Development and Utility of an Inhalation-based Biopharmaceutics Classification System (iBCS) focuses on the development and utility of a proposed classification for inhaled drugs based on physicochemical and drug product performance attributes.
Wenlei Jiang from US-FDA is the moderator, speakers are Jayne Hastedt and Per Bäckman. Panel members are primarily invited experts from FDA like Bing Cai, Ross Walenga, Bryan Newman, Bhagwant Rege and Renishkumar Delvadia. From Industry Ajit Narang (Oric Pharmaceuticals) and Barbara Schug (SocraTec R&D) are invited.